Reuters logo
BRIEF-Novartis Division Sandoz Says New Phase I Data Showing Proposed Biosimilar Pegfilgrastim Matches Reference Medicine‍​
December 8, 2017 / 6:46 AM / 6 days ago

BRIEF-Novartis Division Sandoz Says New Phase I Data Showing Proposed Biosimilar Pegfilgrastim Matches Reference Medicine‍​

Dec 8 (Reuters) - Novartis:

* DIVISION SANDOZ SAYS NEW PHASE I DATA SHOWING PROPOSED BIOSIMILAR PEGFILGRASTIM MATCHES REFERENCE MEDICINE‍​ Source text for Eikon: Further company coverage: (Reporting by John Miller)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below